# The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas

> **NCT05187091** · PHASE3 · RECRUITING · sponsor: **All India Institute of Medical Sciences** · enrollment: 136 (estimated)

## Conditions studied

- Head and Neck Neoplasms
- Swallowing Sparing IMRT

## Interventions

- **RADIATION:** Swallowing and submandibular sparing IMRT
- **RADIATION:** Standard IMRT with medical CRT/RT
- **DRUG:** Cisplatine

## Key facts

- **NCT ID:** NCT05187091
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-12
- **Primary completion:** 2026-08-12
- **Final completion:** 2026-12
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05187091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05187091, "The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05187091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*